Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
Clinical trial NCT04187495 · UNKNOWN
Trial details
- NCT number
- NCT04187495
- Sponsor
- Maxinovel Pty., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2022-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.